Andi Haswidi
As the head of ASEAN Research, Andi focuses on anchoring research reports and writing data-led stories at DealStreetAsia. He is an accomplished researcher, journalist and author. His first book, KOPI: Indonesian Coffee Craft & Culture, was published in 2018.
Stories by Andi Haswidi
Current macroeconomic conditions remain attractive for private credit, says KKR
Sectors such as IT and healthcare provide opportunities for private credit to step in, says SJ Lim, MD, Asia Credit, KKR.
LPs now have a better understanding of the PE opportunities in SE Asia: Novo Tellus
Novo Tellus Fund III was the only SE Asia-focused PE fund that closed above target in 2023.
Data Vantage: Maya Innovations, Nhi Dong 315, Ailytics and ION Mobility in focus
Philippine fintech giant Maya Innovations received fresh capital from PLDT and others as part of a recent funding round.
SE Asia-focused PE funds salvage 2023 performance with strong H2 fundraising
Six SE Asia-focused funds closed in 2023, raising $2 billion in new capital.
Data Vantage: Asia Healthcare, ANEXT, GreenArc Capital, Little Farms and Revi in focus
TPG Capital and GIC have topped up their investments in Asia Healthcare Holdings.
Data Vantage: Tyme Group, Atlan, KinRoss, AwanTunai, Koppiku and LivFresh in focus
Singapore-headquartered digital banking group Tyme Group has received a fresh capital injection from a PE firm.
Data Vantage: Droom, Ai Palette, RaRa Delivery, UangCermat and Hepmil in focus
Indian automobile marketplace Droom received capital from investors, including 57 Stars and SevenTrainVentures, last week.
Southeast Asia’s VCs close fewer funds in 2023 amid global LP pullback
Regional VCs closed 25 funds last year, a drop of over 32% from 2022's historical peak.
Data Vantage: DayaTani, Noomoo, Ketomei, PDAX and Mighty Bear report updates
Indonesian agritech firm DayaTani added Northstar Ventures, BRI Ventures and Gentree Fund to its cap table this week.
Data Vantage: DigiAsia, InCorp, Box Vietnam, Paper.id and Alodokter report updates
Indonesian fintech firm DigiAsia Bios issued new shares to existing shareholders and new investors last week.